Device Trial Radar · NCT04241003
Effects of the SmartDrive on Mobility, Activity and Shoulder Pain Among People With SCI Using Manual Wheelchairs
Last checked: Nov 20, 2026Latest source record: Feb 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Jun 11, 2019
Primary completion
Nov 9, 2020
Study completion May 14, 2021
Sponsor
- Lead sponsor
- Permobil, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 27, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective study of manual wheelchair users with spinal cord injury (SCI). The users will be their own controls. The primary purpose of the study is to evaluate the ability of the power assist device SmartDrive to increase the ability to be mobile.
Conditions
- Spinal Cord Injuries
Interventions
SmartDrive Mx2+Device
Rear-mounted power assist
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in wheelchair usage per day (time)Time frame: Two weeks during baseline (without SmartDrive) and two weeks during intervention (with SmartDrive)
- Change in wheelchair usage per day (distance)Time frame: Two weeks during baseline (without SmartDrive) and two weeks during intervention (with SmartDrive)
- Change in activity level of patient reported wheelchair useTime frame: Two weeks during baseline (without SmartDrive) and two weeks during intervention (with SmartDrive)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stiftelsen Spinalis
Solna, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.